摘要
【摘 要】目的：探究对疗食管癌患者应用胸腔镜联合腹腔镜的治疗效果。方法：选择本院 2017年 3月至 2018年 4月期间进行治疗的 96例食管癌患者作为此次研究对象，根据不同的治疗方式将其均分为实验组和对照组，每组各 48例。实验组通过胸腔镜联合腹腔镜进行治疗，对照组通过开胸三切口根治术进行治疗。将两组患者的治疗后术后生存状态、并发症发生率和各项临床数据（手术出血量、手术时间、住院时间、术后胸腔引流量）进行比较。结果：实验组并发症总发生率（ 10.41%）显著高于对照组（ 33.33%），实验组患者的手术时间、术中出血量、术后胸腔引流量以及住院的时间全部低于对照组，实验组术后生存率（ 85.42%）显著高于对照组（ 70.83%），差异存在统计学意义（ P<0.05）。结论：对食管癌应用胸腔镜联合腹腔镜进行治疗，具有良好的临床效果，具有安全性高的特点，同时降低术后并发症发生率，有利于患者预后和生活质量的提升。
【关键词】胸腔镜；腹腔镜；食管癌
[Abstract] Objective: To explore the therapeutic effect of thoracoscopy combined with laparoscopy in the treatment of esophageal cancer. Methods: 96 patients with esophageal cancer treated in our hospital from March 2017 to April 2018 were selected as the subjects of this study. According to different treatment methods, they were divided into experimental group and control group, 48 cases in each group. The experimental group was treated by thoracoscopy combined with laparoscopy, and the control group was treated by three incision radical operation. The survival status, complication rate and clinical data (bleeding volume, operation time, hospitalization time, postoperative thoracic drainage volume) were compared between the two groups. Results: the total incidence of complications in the experimental group (10.41%) was significantly higher than that in the control group (33.33%). The operation time, intraoperative bleeding volume, postoperative thoracic drainage volume and hospitalization time in the experimental group were all lower than those in the control group. The postoperative survival rate in the experimental group (85.42%) was significantly higher than that in the control group (70.83%). The difference was statistically significant (P < 0.05). Conclusion: thoracoscopy combined with laparoscopy has good clinical effect and high safety in the treatment of esophageal cancer. At the same time, it can reduce the incidence of postoperative complications and improve the prognosis and quality of life of patients.
出版日期
2020年04月27日（中国期刊网平台首次上网日期，不代表论文的发表时间）
